Stuart Arbuckle, who’s been with Vertex since 2012, plans to retire from his role in July. His departure comes as Vertex ...

Shares of Vertex Pharmaceuticals (VRTX) surged Friday, a day after the drugmaker reported federal regulators have approved its non-opioid painkiller, the first such drug to head to market in two ...

Biogen Inc. CEO Christopher Viehbacher gave investors an overview of what type of deals the company is looking for Wednesday ...

Everyone knows that shampooing and conditioning is the most important part of the hair care regime, cleaning the residue from your scalp, but not everyone knows the importance of the shampoo they ...

A holistic or integrative approach to hair loss considers the hair growth cycle and hair loss from a nutritional, ...

Despite its popularity on TikTok, scalp oiling is nothing new ... Dr. Kopelman explains that this could be in part owing to pumpkin seed oil’s role as a dihydrotestosterone blocker ...

Q4 2024 Earnings Call Transcript February 11, 2025 Royalty Pharma plc misses on earnings expectations. Reported EPS is ...

16.0% of Oncternal Therapeutics shares are owned by institutional investors. Comparatively, 91.0% of Vertex Pharmaceuticals shares are owned by institutional investors. 11.2% of Oncternal ...

The team behind Seattle’s most famous fine-dining restaurant, Canlis, will be parting ways. Third-generation owner Brian Canlis will leave the restaurant (and his brother, Mark) in June to ...

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.

But just when we thought it was officially buried in the style graveyard, the side parting is making a quiet, yet undeniable ...